Search for Clinical Trial Results
Bile Duct Cancer - 122 Studies Found
Status | Study |
Suspended |
Study Name: Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer Condition: Bile Duct Cancer Date: 2008-02-19 Interventions:
|
Suspended |
Study Name: A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct Cancer Condition:
Date: 2011-03-15 Interventions: Drug: Fluorouracil implant Before the abdomen was closed, fluorouracil implant 1000mg was sprayed evenly |
Terminated |
Study Name: Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer Condition:
Date: 2002-02-14 Interventions:
|
Completed |
Study Name: A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers Condition:
Date: 2008-10-22 Interventions: Device: Probe-based confocal laser endomicroscopy ERCP with or without cholangiopancreatoscopy will be p |
Completed |
Study Name: Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma Condition: Non-curative Resectable Bile Duct Carcinoma Date: 2009-11-16 Interventions: Drug: Temoporfin Drug treatment: Temoporfin 0.15 mg/kg bod |
Recruiting |
Study Name: Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours Condition: Bile Duct Cancer Date: 2015-10-26 Interventions:
|
Recruiting |
Study Name: Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy Condition: Bile Duct Cancer Date: 2010-12-07 Interventions: Dietary Supplement: Oral IMPACT oral supplement for 5 days(1L/day) before surgery of a formula enriched |
Recruiting |
Study Name: CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery Condition:
Interventions: Drug: 6,8-bis(benzylthio)octanoic acid Given IV Othe |
Recruiting |
Study Name: Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer Condition:
Interventions: |
Enrolling by invitation |
Study Name: Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer Condition:
Date: 2009-03-31 Interventions: Drug: Cox2 inhibitor (Celecoxib) From postoperative third day, administration will be started celecoxib |